Trial · NCT07540312
A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
This prospective, interventional trial is intended to determine the safety and effectiveness of the Variable Compression System (VCS) device for Irritable Bowel
- Status
- Recruiting
- Sponsor
- PGP Health
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 20 participants (planned)
- Start
- May 21, 2025
- Primary completion
- May 1, 2026
- Conditions
- IBS (Irritable Bowel Syndrome)
Summary
This prospective, interventional trial is intended to determine the safety and effectiveness of the Variable Compression System (VCS) device for Irritable Bowel Syndrome (IBS). This pilot study will enroll 20 subjects who will be required to wear the VCS device for a minimum of 6 hours a day and follow up at 21 days, 8 weeks, and 6 months post-device administration.
Interventions
- Variable Compression System Device
Locations
1 country: United States.
| Facility | City | Country |
|---|---|---|
| Central Florida Gastro Research | Kissimmee, Florida | United States |
| UChicago Medicine AdventHealth Medical Group Gastroenterology at Bolingbrook | Bolingbrook, Illinois | United States |
| Delta Gastroenterology PC | Southhaven, Mississippi | United States |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.